EvokAI Creative Labs Inc. (OKAIF)
| Market Cap | 612.17K |
| Revenue (ttm) | n/a |
| Net Income | -13.63M |
| EPS | -1.58 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Average Volume | 343 |
| Open | 0.1710 |
| Previous Close | 0.3030 |
| Day's Range | 0.1710 - 0.1710 |
| 52-Week Range | 0.1710 - 0.3030 |
| Beta | -1.64 |
| RSI | n/a |
| Earnings Date | Apr 29, 2026 |
About EvokAI Creative Labs
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company’s artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and pr... [Read more]
Financial Performance
Financial StatementsNews
EvokAI Creative Labs Sets Date for Share Consolidation
VANCOUVER, BC / ACCESS Newswire / February 3, 2025 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development o...
EvokAI Creative Labs Receives CE Mark Approval for Its MDM Flex Sensor to Transform the Management of Parkinson's Disease
VANCOUVER, BC / ACCESSWORE / October 30, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of tra...
EvokAI Creative Labs Files Final Base Shelf Prospectus
VANCOUVER, BC / ACCESSWIRE / October 25, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of transformational...
EvokAI Creative Labs Initiates CE Mark Certification for Innovative Parkinson's Disease Technology
VANCOUVER, BC / ACCESSWIRE / September 27, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of t...
EvokAI Creative Labs Announces Trading on the OTCQB(R) and DTC Eligibility as Part of Its Market Expansion
VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of transf...